Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Type 1 DiabetesChildren & TeensInfectious DiseaseIssue 701

Type of Enterovirus Linked to Type 1 Diabetes

Researchers have homed in on the group B coxsackie viruses....

Advertisement

Although there has been a considerable amount of research describing the link between type 1 diabetes and enterovirus, which is comprised of more than 100 types including the virus responsible for polio, it was not until recently that researchers from two independent studies determined the specific type of enterovirus that can attack the insulin-producing cells in the pancreas and lead to type 1 diabetes.

Enteroviruses can infect anyone; however, they are more common among infants, children and teenagers because of their lack of immunity. One of the two studies that identified the specific type of enterovirus responsible for causing type 1 diabetes involved children at genetic risk from birth until age 15 or diagnosis of the disease. This study was known as the Finnish Type 1 Diabetes Prediction and Prevention (DIPP) study. The other study, known as the VirDiab study, involved children with newly diagnosed diabetes. Both studies identified that the group B coxsackie viruses were associated with the risk of developing type 1 diabetes; whereas no association with the other 35 types was observed. The group B coxsackie viruses include six enteroviruses.

Researchers said that a vaccine against the virus, similar to a polio vaccine, might be an option eventually in preventing or delaying the onset of type 1 diabetes.

Diabetes, October 2013
 
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 01 November, 2013 and appeared in  Type 1 DiabetesChildren & TeensInfectious DiseaseIssue 701

Past five issues: Diabetes Clinical Mastery Series Issue 211 | Issue 751 | Humulin Insulin Special Edition October 2014 | Diabetes Clinical Mastery Series Issue 210 | Issue 750 |

2014 Most Popular Articles:

FDA Approves Once-Weekly GLP-1 Diabetes Treatment Regimen for T2DM
Posted September 25, 2014
Stanley Schwartz, MD: A New Way of Classifying Diabetes - The Beta-Cell Centric Approach
Posted September 29, 2014
Two Positive Phase 3 Trials for ITCA 650 (Exenatide, a GLP-1 Agonist) in Type 2 Diabetes
Posted October 10, 2014
EASD: Insulin Pumps Lower Mortality Rate 29% Compared to Multiple Injections in T1DM
Posted October 03, 2014
Best Insulin Regimen for Type 1's
Posted October 10, 2014
GLP-1 Agonist Medications Chart
Posted September 23, 2014
FDA Approves an Eye Drug for Diabetic Patients
Posted September 25, 2014
Non-Caloric Artificial Sweeteners May Induce Glucose Intolerance
Posted October 10, 2014
Handbook of Diabetes, 4th Edition, Excerpt #11: Diabetic Ketoacidosis, Hyperglycaemic Hyperosmolar State and Lactic Acidosis
Posted September 27, 2014
Best Glycemic Control for T2DM Attained with GLP-1 Agonist + Insulin
Posted September 25, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Do your teenage patients manage their diabetes well?
CME/CE of the Week
Patti Geil, MS, RD, FADA, CDE

Category: Nutrition
Credits: .75



Search Articles On Diabetes In Control